In 2026, the ulcerative colitis medication Rinvoq by AbbVie is forecasted to generate 5.1 billion U.S. dollars in sellside revenue. This statistic illustrates the sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026.
Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026
(in million U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Evaluate Vantage. (May 28, 2021). Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026 (in million U.S. dollars) [Graph]. In Statista. Retrieved December 30, 2024, from https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/
Evaluate Vantage. "Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026 (in million U.S. dollars)." Chart. May 28, 2021. Statista. Accessed December 30, 2024. https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/
Evaluate Vantage. (2021). Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026 (in million U.S. dollars). Statista. Statista Inc.. Accessed: December 30, 2024. https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/
Evaluate Vantage. "Sales Forecast of Select Medications for Ulcerative Colitis Worldwide from 2021 to 2026 (in Million U.S. Dollars)." Statista, Statista Inc., 28 May 2021, https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/
Evaluate Vantage, Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026 (in million U.S. dollars) Statista, https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/ (last visited December 30, 2024)
Sales forecast of select medications for ulcerative colitis worldwide from 2021 to 2026 (in million U.S. dollars) [Graph], Evaluate Vantage, May 28, 2021. [Online]. Available: https://www.statista.com/statistics/1240402/sales-forecast-ulcerative-colitis-medications-worldwide/
